Home › Cutaneous T-Cell Lymphoma › NCT04670874

Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

Assessment of Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Agreement to participate in the research study
* Presumed or confirmed diagnosis of CL

About the study

This study assesses the quality of life in patients with cutaneous lymphoma diagnosis as it relates to their personal, clinical, and therapeutic information using the Skindex29 questionnaire and also assesses patients' understanding of their diagnosis and need for resources related to their care. Cutaneous lymphomas are a rare type of blood cancers (non-Hodgkin lymphoma) that present in the skin. The information gained from this study, may help researchers improve quality of life in cutaneous lymphoma patients.

What is being tested

• Quality-of-Life Assessment (other)
• Questionnaire Administration (other)

Sponsor: City of Hope Medical Center · Participants: 1,250 · Started: Aug 17, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT04670874

Locations in the U.S.

Conditions

• Cutaneous T-Cell Lymphoma

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.